Valuation Indivior Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq 23:00:00 02/10/2026 +03			5-day change	1st Jan Change
35.71 ^USD	+0.93%		-0.31%	-0.47%

09-17	Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend, Payable on or About November 6, 2026	CI
09-17	Indivior Sets Special Cash Dividend at $8.13 a Share Contingent on Completion of Supernus Merger	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,423	2,969	2,085	1,553	4,480	4,214	-	-
Change	-	22.54%	-29.76%	-25.5%	188.39%	-5.93%	-	-
Enterprise Value (EV) ¹	1,563	2,435	2,008	1,567	4,604	4,202	3,644	3,024
Change	-	55.81%	-17.52%	-21.95%	193.72%	-8.73%	-13.27%	-17.03%
P/E	12.8x	-57.2x	1,527x	-34.5x	21.9x	9.6x	8.7x	7.95x
PBR	-	59.3x	-	-8.02x	-45.8x	-	-	-
PEG	-	0x	-15x	0x	-0x	0x	0.8x	0.85x
Capitalization / Revenue	3.06x	3.29x	1.91x	1.31x	3.62x	3.16x	3.01x	2.83x
EV / Revenue	1.98x	2.7x	1.84x	1.32x	3.72x	3.15x	2.6x	2.03x
EV / EBITDA	7.74x	10.8x	6.97x	4.64x	10.8x	5.77x	4.61x	3.52x
EV / EBIT	8.36x	11.5x	7.47x	5.02x	11.1x	6.1x	4.94x	3.8x
EV / FCF	4.61x	-10.7x	-4.86x	-196x	-49.5x	8.25x	6.7x	4.89x
FCF Yield	21.7%	-9.32%	-20.6%	-0.51%	-2.02%	12.1%	14.9%	20.4%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.35	-0.38	0.01	-0.36	1.64	3.72	4.105	4.49
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	791	901	1,093	1,188	1,239	1,332	1,400	1,489
EBITDA ¹	202	225	288	338	428	728.4	790.8	859.6
EBIT ¹	187	212	269	312	415	688.8	737.7	795.7
Net income ¹	205	-53	2	-48	210	474.3	530	582.9
Net Debt ¹	-860	-534	-77	14	124	-12.5	-570	-1,191
Reference price ²	17.25	21.75	15.27	12.43	35.88	35.71	35.71	35.71
Nbr of stocks (in thousands)	140,437	136,489	136,551	124,970	124,854	118,014	-	-
Announcement Date	2/16/22 A	2/16/23 A	2/22/24 A	2/20/25 A	2/26/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
INDIVIOR PHARMACEUTICALS, INC.	9.6x	3.15x	5.77x	-	4.21B
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.7x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	24.91x	6.19x	16.12x	2.29%	370.14B
Weighted average by Cap.	31.78x	7.60x	18.59x	1.96%